The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Finding the Mystery to Trigger-Induced Atrial Fibrillation

An effort to produce recommendations for hospitalists to treat atrial fibrillation led to a wide-ranging search for answers.

Getting Blood Into Ambulances Matters in Trauma Cases

More hospitals and EMS systems are stocking blood to begin transfusions in trauma patients. Many believe it is saving lives.

GSK's Jemperli Meets Main Goal in Mid-stage Rectal Cancer Trial

GSK said on Monday its cancer drug Jemperli met the primary goal of a ⁠mid-stage trial, with a clinically significant rate of patients showing no detectable signs of cancer...

Screening Reveals High Rate of EoE in Pediatric Asthma

Symptom-based screening in pediatric asthma and allergy clinics identifies a previously unrecognized high prevalence of eosinophilic esophagitis.

Alcohol Emergencies: When Is It More Than Intoxication?

Experts outline practical strategies to recognize acute alcohol-related conditions, avoid diagnostic bias, and identify life-threatening complications in the emergency department.

German Hospital Treats US Ebola Patient Infected in Congo

A U.S. citizen infected with the Ebola virus in Democratic Republic of Congo ⁠was admitted to Frankfurt University Hospital early on Monday, officials said.

Todays Updates

An Oral Ketamine Drug for Depression — Minus the Trip?

A novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.

Info on Risk for Prostate Cancer Spurs Decision-Making

Men who receive personalized estimates of the likelihood of raised prostate-specific antigen levels are more likely to decide to get screening than those who receive general information on pros and cons.

Fast Symptom Relief in Ulcerative Colitis: Which Rx Wins?

Upadacitinib and infliximab offer rapid relief from symptoms in biologic-naive patients with moderate-to-severe ulcerative colitis.

Europe’s AI Reality: Practice Outpaces Policy and Reviews

Clinicians and patients are already relying on AI, while hospitals are still building the oversight to keep up.

Cognitive Benefit of Healthy Living Confirmed: LatAm-FINGERS

A culturally tailored lifestyle program improves cognition significantly more than standard health advice among older adults at risk for dementia across Latin America.

Health Issues Tied to Behaviours in Intellectual Disability

People with intellectual disabilities who have physical health problems or sensory impairments face a higher risk for challenging behaviours.

Rimegepant Effective in Treatment-Resistant Migraine

Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.

Todays Updates

An Oral Ketamine Drug for Depression — Minus the Trip?

A novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.

Info on Risk for Prostate Cancer Spurs Decision-Making

Men who receive personalized estimates of the likelihood of raised prostate-specific antigen levels are more likely to decide to get screening than those who receive general information on pros and cons.

Fast Symptom Relief in Ulcerative Colitis: Which Rx Wins?

Upadacitinib and infliximab offer rapid relief from symptoms in biologic-naive patients with moderate-to-severe ulcerative colitis.

Europe’s AI Reality: Practice Outpaces Policy and Reviews

Clinicians and patients are already relying on AI, while hospitals are still building the oversight to keep up.

Cognitive Benefit of Healthy Living Confirmed: LatAm-FINGERS

A culturally tailored lifestyle program improves cognition significantly more than standard health advice among older adults at risk for dementia across Latin America.

Health Issues Tied to Behaviours in Intellectual Disability

People with intellectual disabilities who have physical health problems or sensory impairments face a higher risk for challenging behaviours.

Rimegepant Effective in Treatment-Resistant Migraine

Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.

Latest News

An effort to produce recommendations for hospitalists to treat atrial fibrillation led to a wide-ranging search for answers.

More hospitals and EMS systems are stocking blood to begin transfusions in trauma patients. Many believe it is saving lives.

GSK said on Monday its cancer drug Jemperli met the primary goal of a ⁠mid-stage trial, with a clinically significant rate of patients showing no detectable signs of cancer...

Symptom-based screening in pediatric asthma and allergy clinics identifies a previously unrecognized high prevalence of eosinophilic esophagitis.

Experts outline practical strategies to recognize acute alcohol-related conditions, avoid diagnostic bias, and identify life-threatening complications in the emergency department.

A U.S. citizen infected with the Ebola virus in Democratic Republic of Congo ⁠was admitted to Frankfurt University Hospital early on Monday, officials said.

News All Time

What's Really Killing Patients With Late-Stage PD?

A decade-long study finds aspiration pneumonia as the leading cause of death in late-stage Parkinson's disease, and worsening motor function, cognition, and depression predict a higher risk for death.

Lower Breathing Pressure Tied to Complications in Preemies

In premature babies, lower breathing pressure at birth is linked to a higher likelihood of needing a breathing tube and later lung and eye complications.

Inside Isolation Units for Highly Contagious Diseases

The Spanish model highlights the infrastructure, training, and containment measures required for high-risk infectious disease care.

Education Nudges Patients With CKD Away From Haemodialysis

Structured predialysis education may help patients with chronic kidney disease stages 4 and 5 to choose peritoneal dialysis over haemodialysis, a Polish study finds.

Trump CDC Nominee Schwartz Set for July 15 US Senate Confirmation Hearing

Erica Schwartz, President Donald Trump's nominee to lead the U.S. Centers for Disease Control and Prevention, will appear before the Senate Committee on Health, Education,...

Pernicious Anemia: How a Fatal Disease Became Treatable

Once nearly always fatal, pernicious anemia became treatable through a series of discoveries linking the stomach, liver, and ultimately vitamin B12.

Uveitis Patterns Vary in Relation to Spondyloarthritis Type

Patients with peripheral forms of spondyloarthritis show a higher prevalence of different uveitis patterns than those with axial forms.

Children With Sesame Allergy Often Tolerate Intact Seeds

Most children with sesame allergy who develop reactions to concentrated sesame products tolerate whole seeds during supervised oral food challenge, supporting individualized dietary counseling.

The Essential Clinical Research You’re Probably Not Reading

Qualitative research has long been viewed as less rigorous and less important — but that’s changing. Here’s where to find the highest-quality studies and how to use them to help your patients.

AI Is Making Uneven Inroads in Pulmonary Medicine

AI tools are proliferating across pulmonary medicine and critical care, with promising early results in diagnostics and prediction, but significant gaps between development and deployment.

Pain Persists Despite Low Inflammation in Many With Early RA

Patients newly diagnosed with rheumatoid arthritis often experience unacceptable pain at 2 years despite having low levels of inflammation, a study finds.

Can CRISPR Make CAR T Safer and More Scalable?

Combining CRISPR/Cas9 with CAR T aims to let patients’ T cells be reprogrammed in vivo, potentially lowering cost and expanding use to solid tumors and autoimmune disease.

Abrocitinib Boosts Skin Clearance and Itch Relief in AD

Abrocitinib can help achieve minimal disease activity in patients with atopic dermatitis irrespective of previous exposure to dupilumab, a post hoc study shows.

Limited Data for JAK Inhibitors in SSc Described in Study

In patients with systemic sclerosis, JAK inhibitors show comparable effectiveness to standard immunosuppressants, but many stop therapy due to treatment failure or adverse events.

When Patient Self-Scheduling Collides With Acute Care

Many health systems are giving patients the power to schedule appointments and procedures. What happens when that autonomy creates down-stream problems?

When Patients Arrive With AI Diagnoses

Patients increasingly come to visits with AI-generated ideas and online research, forcing doctors to balance information, uncertainty, and reassurance in real time.

Recommended News For You

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

After all, Pulled Myeloma Drug May Help Treat the Illness.

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

Insurance Claim Denials for Preventive Care More Common in At-Risk Patients

Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants

Surviving cancer, still suffering: Survey reveals gaps in follow‑up care

FDA Approves Treosulfan as Part of AML/MDS Conditioning Regimen

Recommended Articles For You

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine 

A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer 

Understanding Colon Cancer: Symptoms, Causes, and Treatment Options  

Obesity as a major risk factor for cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Why palliative care goes hand in hand with treatment for people with cancer: Q&A

2.

Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.

3.

Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting

4.

Inner Thoughts of Leonard Bernstein, the "Maestro".

5.

PSA Screening Overdiagnosis Rises Sharply With Age

1.

Generative AI for Adaptive Oncology Trial Design

2.

Transformative Frameworks in Oncology for Better Care

3.

Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain

4.

Understanding the Importance of Red Cell Distribution Width (RDW) in Blood Tests 

5.

Tumor Evolution Forecasting for Precision Oncology Decisions

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

2.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II

4.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

5.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot